Search Results - "SCHRIMPF, Michael R"

Refine Results
  1. 1

    Antiviral Drug Discovery for the Treatment of COVID-19 Infections by Ng, Teresa I, Correia, Ivan, Seagal, Jane, DeGoey, David A, Schrimpf, Michael R, Hardee, David J, Noey, Elizabeth L, Kati, Warren M

    Published in Viruses (04-05-2022)
    “…The coronavirus disease 2019 (COVID-19) pandemic is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a recently emerged human…”
    Get full text
    Journal Article
  2. 2

    Development of a sensitive high-throughput enzymatic assay capable of measuring sub-nanomolar inhibitors of SARS-CoV2 Mpro by Kovar, Peter, Richardson, Paul L, Korepanova, Alla, Afanador, Gustavo A, Stojkovic, Vladimir, Li, Tao, Schrimpf, Michael R, Ng, Teresa I, Degoey, David A, Gopalakrishnan, Sujatha M, Chen, Jun

    Published in SLAS discovery (01-09-2024)
    “…The SARS-CoV-2 main protease (Mpro) is essential for viral replication because it is responsible for the processing of most of the non-structural proteins…”
    Get full text
    Journal Article
  3. 3

    SAR of α7 nicotinic receptor agonists derived from tilorone: Exploration of a novel nicotinic pharmacophore by Schrimpf, Michael R., Sippy, Kevin B., Briggs, Clark A., Anderson, David J., Li, Tao, Ji, Jianguo, Frost, Jennifer M., Surowy, Carol S., Bunnelle, William H., Gopalakrishnan, Murali, Meyer, Michael D.

    Published in Bioorganic & medicinal chemistry letters (15-02-2012)
    “…The well-known interferon-inducer tilorone was found to possess potent affinity for the agonist site of the α7 neuronal nicotinic receptor (Ki=56nM). SAR…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    SAR of alpha 7 nicotinic receptor agonists derived from tilorone: Exploration of a novel nicotinic pharmacophore by Schrimpf, Michael R, Sippy, Kevin B, Briggs, Clark A, Anderson, David J, Li, Tao, Ji, Jianguo, Frost, Jennifer M, Surowy, Carol S, Bunnelle, William H, Gopalakrishnan, Murali, Meyer, Michael D

    Published in Bioorganic & medicinal chemistry letters (15-02-2012)
    “…The well-known interferon-inducer tilorone was found to possess potent affinity for the agonist site of the alpha 7 neuronal nicotinic receptor (Ki = 56 nM)…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Preparation and characterization of N-(3-pyridinyl) spirocyclic diamines as ligands for nicotinic acetylcholine receptors by SIPPY, Kevin B, ANDERSON, David J, BUNNELLE, William H, HUTCHINS, Charles W, SCHRIMPF, Michael R

    Published in Bioorganic & medicinal chemistry letters (15-03-2009)
    “…Several N-pyridin-3-yl spirobicyclic diamines, designed as conformationally restricted analogs of tebanicline (ABT-594), were synthesized as novel ligands for…”
    Get full text
    Journal Article
  11. 11

    Design of ligands for the nicotinic acetylcholine receptors: the quest for selectivity by Bunnelle, William H, Dart, Michael J, Schrimpf, Michael R

    “…In the last decade, nicotinic acetylcholine receptors (nAChRs) have emerged as important targets for drug discovery. The therapeutic potential of nicotinic…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Structure–activity relationships of N-substituted ligands for the α7 nicotinic acetylcholine receptor by Mortell, Kathleen H., Schrimpf, Michael R., Bunnelle, William H., Anderson, David J., Gronlien, Jens Halvard, Hagene, Kirsten Thorin, Gopalakrishnan, Murali

    “…A series of α7 neuronal nicotinic acetylcholine receptor ligands were designed based on a structural combination of a potent, but non-selective ligand,…”
    Get full text
    Journal Article
  16. 16

    An automated electrophysiological assay for differentiating Ca(v)2.2 inhibitors based on state dependence and kinetics by Swensen, Andrew M, Niforatos, Wende, Vortherms, Timothy A, Perner, Richard J, Li, Tao, Schrimpf, Michael R, Scott, Victoria E, Lee, Lance, Jarvis, Michael F, McGaraughty, Steve

    Published in Assay and drug development technologies (01-12-2012)
    “…Ca(V)2.2 (N-type) calcium channels are key regulators of neurotransmission. Evidence from knockout animals and localization studies suggest that Ca(V)2.2…”
    Get more information
    Journal Article
  17. 17

    Discovery of fused azetidines as novel selective α4β2 neuronal nicotinic receptor (NNR) agonists by Ji, Jianguo, Bunnelle, William H., Li, Tao, Pace, Jennifer M., Schrimpf, Michael R., Sippy, Kevin B., Anderson, David J., Meyer, Michael D.

    Published in Pure and applied chemistry (01-01-2005)
    “…An efficient synthesis of (1 ,5 )-6-(5-cyano-3-pyridinyl)-3,6-diaza-bicyclo[3.2.0]heptane , a novel potent selective neuronal nicotinic receptor (NNR) agonist,…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Structure-activity relationships of N-substituted ligands for the a7 nicotinic acetylcholine receptor by Mortell, Kathleen H, Schrimpf, Michael R, Bunnelle, William H, Anderson, David J, Gronlien, Jens Halvard, Hagene, Kirsten Thorin, Gopalakrishnan, Murali

    Published in Bioorganic & medicinal chemistry letters (01-01-2010)
    “…A series of a7 neuronal nicotinic acetylcholine receptor ligands were designed based on a structural combination of a potent, but non-selective ligand,…”
    Get full text
    Journal Article
  20. 20